Method for immune system activation by administration of a .beta.(1-3) glucan which is produced by Saccharomyces cerevisiae strain R4
US5504079A · kind A · utility
80Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 14, 1994 |
| Grant date | Apr 2, 1996 |
| Priority date | — |
| Expiry date | Nov 14, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Modified yeast cell wall glucans are administered to patients who are at risk for infection due to imminent surgery, chemotherapy or other treatment which affects the immune system, in order to mobilize the cellular defense mechanisms and boost the immune response of the patient before, during and after the surgery, chemotherapy or other treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.